<DOC>
	<DOC>NCT00116220</DOC>
	<brief_summary>This clinical study was to determine if the use of 6 months of total androgen suppression (hormonal therapy) when added to radiation therapy for localized-high risk prostate cancer would improve overall survival.</brief_summary>
	<brief_title>Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer</brief_title>
	<detailed_description>This was a randomized study comparing external beam radiation therapy with total androgen ablation for 6 months with radiation therapy alone. Drugs were given 2 months prior, 2 months during, and 2 months after radiation therapy. Eulexin and Lupron or Zoladex was used in this study.</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Flutamide</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Biopsy proven prostate cancer Negative bone scan Lymph nodes by CT or MRI Adequate blood work Performance Status ECOG 01 Life expectancy of at least 10 years &gt;40 years of age Prior history of malignancy Prior hormonal therapy or chemotherapy Prior pelvic radiation therapy Unable to tolerate lying still 510 minutes/day</criteria>
	<gender>Male</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>Total Androgen Suppression</keyword>
	<keyword>endorectal coil MRI</keyword>
	<keyword>External Beam Radiation Therapy</keyword>
	<keyword>Prostate Cancer- High Risk, clinically Organ-Confined</keyword>
</DOC>